Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Although the incidence and prevalence of irAEs have been well characterized in the literature, less is known about the cumulative incidence rate of irAEs. We studied the cumulative incidence of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Nuzzo, Pier Vitale, Pond, Gregory R, Abou Alaiwi, Sarah, Nassar, Amin H, Flippot, Ronan, Curran, Catherine, Kilbridge, Kerry L, Wei, Xiao X, McGregor, Bradley A, Choueiri, Toni, Harshman, Lauren C, Sonpavde, Guru
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174062/
https://ncbi.nlm.nih.gov/pubmed/32234849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000371
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars